PBMs, Big Pharma face off in House hearingSep 19, 2023Pharmacy benefit managers emerged as public enemy No. 1 in a congressional hearing Tuesday, underscoring growing bipartisan sympathy for advancing any of the many measures that target drug industry middlemen. Read the full story >
Pharmacy benefit managers emerged as public enemy No. 1 in a congressional hearing Tuesday, underscoring growing bipartisan sympathy for advancing any of the many measures that target drug industry middlemen. Read the full story >
Commentaires